Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$4.02 - $5.89 $179,042 - $262,328
44,538 Added 4127.71%
45,617 $240,000
Q4 2023

Feb 14, 2024

SELL
$1.29 - $5.86 $15,943 - $72,423
-12,359 Reduced 91.97%
1,079 $5,000
Q3 2023

Nov 14, 2023

BUY
$2.88 - $8.8 $5,883 - $17,978
2,043 Added 17.93%
13,438 $45,000
Q2 2023

Aug 14, 2023

BUY
$7.46 - $10.67 $1,574 - $2,251
211 Added 1.89%
11,395 $94,000
Q1 2023

May 15, 2023

BUY
$8.44 - $13.35 $94,392 - $149,306
11,184 New
11,184 $97,000
Q3 2022

Nov 14, 2022

BUY
$6.1 - $11.41 $35,392 - $66,200
5,802 New
5,802 $37,000
Q4 2021

Feb 14, 2022

SELL
$17.36 - $27.36 $349,960 - $551,550
-20,159 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$22.34 - $39.1 $450,352 - $788,216
20,159 New
20,159 $458,000

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $301M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.